Wegovy’s New Weight Loss Pill: What It Changes From A Harvard Doctor

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week. Here’s how it works, who qualifies, how to take it, side effects, cost, and why it matters now.
Pew Research Center

6 facts about obesity and weight loss drugs in the U.S.

About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often.
Axios on MSN

North Carolina's Medicaid program is one of 13 that covers GLP-1s for weight loss

Data: N.C. Department of Health and Human Services; Chart: Axios Visuals North Carolina is one of 13 states whose Medicaid programs cover GLP-1s for weight loss treatment, and their usage in the state ...
The Economist

A second helping of weight-loss drugs is coming

The appetite for weight-loss drugs, known as glp-1 agonists, has been insatiable since they hit the market a decade ago. In 2024 global spending on them reached $54bn, a figure that is sure to rise in ...